Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China
Dalong Zhu,Shenglian Gan,Yu Liu,Jianhua Ma,Xiaolin Dong,Weihong Song,Jiaoe Zeng,Guixia Wang,Wenjuan Zhao,Qiu Zhang,Yukun Li,Hui Fang,Xiaofeng Lv,Yongquan Shi,Haoming Tian,Linong Ji,Xin Gao,Lihui Zhang,Yuqian Bao,Minxiang Lei,Ling Li,Longyi Zeng,Xiaoying Li,Tianxin Hu,Guiyu Zhao,Xiaoyun Ge,Yu Zhao,Xinghua Hou,Yongguo Li,Yi Zhang,Li Chen DIABETES-METABOLISM RESEARCH AND REVIEWS（2017）
AI 理解论文
溯源树
样例
